Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients.
about
ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literatureProgress in childhood cancer: 50 years of research collaboration, a report from the Children's Oncology GroupTargeted Therapies for the Treatment of Pediatric Non-Hodgkin Lymphomas: Present and FutureNon-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges AheadThe effects of DLEU1 gene expression in Burkitt lymphoma (BL): potential mechanism of chemoimmunotherapy resistance in BLPrimary CNS lymphoma in children and adolescents: a descriptive analysis from the International Primary CNS Lymphoma Collaborative Group (IPCG).The combination of monoclonal antibodies and conventional chemotherapy for children with malignant lymphoma: Opportunities and challenges.Non-Hodgkin lymphoma and pre-existing conditions: spectrum, clinical characteristics and outcome in 213 children and adolescentsOutcomes for children and adolescents with cancer: challenges for the twenty-first century.Outcomes of patients with Burkitt lymphoma older than age 40 treated with intensive chemotherapeutic regimens.An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children's Oncology Group study CCG-5961.Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents.Burkitt lymphoma: pathogenesis and immune evasion.Combination of dexamethasone, high-dose cytarabine, and carboplatin is effective for advanced large-cell non-Hodgkin lymphoma of childhood.Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study.Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report.The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomasEfficacy of high-dose methotrexate, ifosfamide, etoposide and dexamethasone salvage therapy for recurrent or refractory childhood malignant lymphoma.Pediatric lymphomas and histiocytic disorders of childhoodAutologous peripheral blood stem cell transplantation in children with refractory or relapsed lymphoma: results of Children's Oncology Group study A5962.Prognostic Value and Clinical Impact of (18)FDG-PET in the Management of Children with Burkitt Lymphoma after Induction Chemotherapy.Minimal disease assessment in the treatment of children and adolescents with intermediate-risk (Stage III/IV) B-cell non-Hodgkin lymphoma: a children's oncology group report.Bilateral burkitt lymphoma of the ovaries: a report of a case in a child with williams syndrome.Children's Oncology Group's 2013 blueprint for research: non-Hodgkin lymphoma.Treatment outcomes in children with Burkitt lymphoma and L3 acute lymphoblastic leukemia treated using the lymphoma malignancy B protocol at a single institution.Pediatric B-cell lymphoma, unclassifiable, with intermediate features between those of diffuse large B-cell lymphoma and Burkitt lymphoma: a report of two cases.The role of FDG-PET/CT in the evaluation of residual disease in paediatric non-Hodgkin lymphomaGenome wide copy number analysis of paediatric Burkitt lymphoma using formalin-fixed tissues reveals a subset with gain of chromosome 13q and corresponding miRNA over expressionLessons from the past: opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies.Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective "Lymphomes Malins B" protocols. A Société Française des Cancers de l'Enfant study.International Pediatric Non-Hodgkin Lymphoma Response Criteria.Revised International Pediatric Non-Hodgkin Lymphoma Staging System.Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profilingRituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: a Children's Oncology Group report.Clinical course and prognostic factors of children with Burkitt's lymphoma in a developing country: the experience of a single centre in BrazilAdvances in paediatric cancer treatmentTargeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes.Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapyPharmacokinetic Properties of Anticancer Agents for the Treatment of Central Nervous System Tumors: Update of the Literature.Paediatric non-Hodgkin lymphoma in low and middle income countries.
P2860
Q21198873-C07A90A1-3CDA-4427-A6B2-88FDE18A535FQ24657000-808E938D-D9C9-4A50-947B-92573FA387EEQ26746934-BA296613-F155-48DA-8A81-E315CE267E67Q26797513-F96110AE-52B7-4D83-9ACE-D7FE58FFDE69Q33709463-852EF793-6047-450A-B364-61AD5F8F866BQ33759495-E00CD78F-F266-42FF-8E29-1F902EB77129Q33802550-07210F47-3257-4E57-99D0-2351E2665124Q33822062-5C995542-782A-485B-BA1F-807500E13FC4Q33897659-602A1798-14D9-4F88-82DB-7C75A2BF6A81Q34018599-3A15DB70-2D9F-4483-9FC8-73782988D899Q34020070-095F360A-6372-4009-B0B1-7E4EB3B2D164Q34025468-163A7C6A-CDC7-4228-8D8A-6F814321D2A0Q34189497-B7836F4B-8623-4BA2-80D0-A0A8A38FD8CFQ34287195-9A545315-F846-430F-93FD-C424E24DF640Q34334050-7792D996-65E7-41FA-93E1-CBACECA1A391Q34344942-2E1976F4-DC20-4144-A9FB-537C4A7C8D95Q34371078-971F2DF6-6D3B-427F-8C94-C81147F03BB3Q34537366-513331C3-AF1F-4276-8948-E691FFFC0E17Q34605894-2CFE2571-ACE6-421C-B751-48DDFB2309CBQ34773043-4EE20236-A41B-461F-B733-877F871380C5Q34931319-35D9546A-FFE0-48BE-836F-CFA32E052420Q35011933-707CDF50-3B0B-4CC7-A3C6-9A55AAB5FB0AQ35043915-85F58827-191B-4180-830C-C529819E6E94Q35083003-8452C768-6814-4A55-8F1C-F5BAD2C7BE5FQ35084407-32FEB2A4-DDB2-4C03-B3DC-67C6A39C593CQ35088498-CC10B131-6C64-41B3-9B21-06EB2927C0CAQ35152064-F8C5DE24-7707-482B-A452-655689146ABCQ35476235-FB66E692-E338-40E6-A733-0D5171F1EB67Q35667279-7A8EBFF7-EF3F-4E08-B07C-4E5F61E23F71Q35669884-1BDBAB56-71EA-4516-BC6B-5E4351E70430Q35708769-F26CD824-35E6-4F81-A1D2-5DCB6C26C664Q35708778-16FA732D-EA28-4955-882C-9747180F2368Q35909668-D2C72771-DA37-46DB-8C71-AD9F4A9E5C70Q35963027-88D1B80A-1FBF-4BDD-BFE3-23A6993F83BEQ36364844-5FE22EF5-649F-4767-9218-C6E2ADD994A6Q36508630-6D2F2754-1A8E-4D1A-A602-169B7179D9A5Q36509645-B8228979-D622-4375-B78E-A36EC815F743Q36529482-94ED633C-DF74-4CC3-8D1D-5512BA6AAFCFQ36600202-3D579F3C-6011-4A57-8D22-07387C0616B6Q36889228-540DA2D6-12A9-44EB-B732-C6C314BF3642
P2860
Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Results of the randomized inte ...... the early responding patients.
@ast
Results of the randomized inte ...... the early responding patients.
@en
type
label
Results of the randomized inte ...... the early responding patients.
@ast
Results of the randomized inte ...... the early responding patients.
@en
prefLabel
Results of the randomized inte ...... the early responding patients.
@ast
Results of the randomized inte ...... the early responding patients.
@en
P2093
P2860
P1433
P1476
Results of the randomized inte ...... the early responding patients.
@en
P2093
Anne Auperin
Catherine Patte
Claire Weston
FAB/LMB96 International Study Committee
Jean Michon
Keith McCarthy
Martine Raphael
Mary Gerrard
Mitchell S Cairo
Richard Sposto
P2860
P304
P356
10.1182/BLOOD-2006-07-036673
P407
P577
2007-04-01T00:00:00Z